As of 2024-12-11, the Intrinsic Value of TME Pharma NV (ALTME.PA) is
-0.75 EUR. This ALTME.PA valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.08 EUR, the upside of TME Pharma NV is
-1,015.32%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.75 EUR
Intrinsic Value
ALTME.PA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.75 - -0.75 |
-0.75 |
-1,015.32% |
| DDM - Stable |
(2.84) - (106.57) |
(54.70) |
-66811.8% |
| DDM - Multi |
(0.56) - (16.19) |
(1.08) |
-1416.8% |
ALTME.PA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
3.45 |
| Beta |
0.53 |
| Outstanding shares (mil) |
42.12 |
| Enterprise Value (mil) |
0.76 |
| Market risk premium |
5.82% |
| Cost of Equity |
5.92% |
| Cost of Debt |
5.00% |
| WACC |
5.88% |